Literature DB >> 9213241

Trophic effects of glicentin on rat small-intestinal mucosa in vivo and in vitro.

S Myojo1, T Tsujikawa, M Sasaki, Y Fujiyama, T Bamba.   

Abstract

To define the role of glicentin the active site of enteroglucagon, we evaluated the trophic effects of recombinant rat glicentin on rat small intestine and IEC-6 cells. In vivo, a significant increase was observed in jejunal wet weight, protein content, DNA content, and alkaline phosphatase activity after the subcutaneous administration of 100 micrograms/kg per day of glicentin for 2 weeks. In the ileum, however, there were no significant differences between the control versus glicentin groups in any of these parameters. Ornithine decarboxylase (ODC) activity 3.5 h after an intraperitoneal injection of glicentin was increased in the jejunal mucosa, but not in the ileal mucosa. In vitro, glicentin, at a dose of more than 100 ng/ml, significantly increased both tritium-thymidine incorporation and the number of IEC-6 cells. These findings indicate that glicentin exerts direct trophic effects on the rat small-intestinal mucosa and on the rat small-intestinal cell line, IEC-6, and that this peptide appears to be an active site of enteroglucagon.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9213241     DOI: 10.1007/bf02934484

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  30 in total

1.  The role of gut-glucagon-like immunoreactants in the control of gastrointestinal epithelial cell renewal.

Authors:  M Gregor; A Stallmach; H Menge; E O Riecken
Journal:  Digestion       Date:  1990       Impact factor: 3.216

2.  An enteroglucagon tumour.

Authors:  S R Bloom
Journal:  Gut       Date:  1972-07       Impact factor: 23.059

3.  Effect of highly purified porcine gut glucagon-like immunoreactivity (glicentin) on glucose release from isolated rat hepatocytes.

Authors:  H I Thieden; J J Holst; J Dich; A Moody; F Sundby
Journal:  Biochim Biophys Acta       Date:  1981-07

4.  Nutrient-independent increases in proglucagon and ornithine decarboxylase messenger RNAs after jejunoileal resection.

Authors:  D B Rountree; M H Ulshen; S Selub; C R Fuller; S R Bloom; M A Ghatei; P K Lund
Journal:  Gastroenterology       Date:  1992-08       Impact factor: 22.682

5.  The trophic effect of epidermal growth factor on morphological changes and polyamine metabolism in the small intestine of rats.

Authors:  T Tsujikawa; T Bamba; S Hosoda
Journal:  Gastroenterol Jpn       Date:  1990-06

6.  Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas.

Authors:  C Orskov; J J Holst; S Knuhtsen; F G Baldissera; S S Poulsen; O V Nielsen
Journal:  Endocrinology       Date:  1986-10       Impact factor: 4.736

7.  Effect of glicentin-related peptides on glucagon secretion in anaesthetized dogs.

Authors:  A Ohneda; T Kobayashi; J Nihei
Journal:  Diabetologia       Date:  1986-06       Impact factor: 10.122

8.  Glucagon 1-21 reduces intestinal epithelial cell proliferation in parenterally fed rats.

Authors:  R A Goodlad; M A Ghatei; S R Bloom; N A Wright
Journal:  Exp Physiol       Date:  1991-11       Impact factor: 2.969

9.  Insulinotropic action of human glicentin in dogs.

Authors:  A Ohneda; K Ohneda; T Nagasaki; K Sasaki
Journal:  Metabolism       Date:  1995-01       Impact factor: 8.694

10.  Effects of EGF and PMA on the growth and proliferation of IEC-6 cells.

Authors:  B S Baliga; S M Borowitz; J A Barnard
Journal:  Biochem Int       Date:  1989-11
View more
  7 in total

Review 1.  The Long Road to the Development of Effective Therapies for the Short Gut Syndrome: A Personal Perspective.

Authors:  Palle Bekker Jeppesen
Journal:  Dig Dis Sci       Date:  2019-10       Impact factor: 3.199

2.  Fasting Circulating Glicentin Increases After Bariatric Surgery.

Authors:  Juliette Raffort; Patricia Panaïa-Ferrari; Fabien Lareyre; Pascale Bayer; Pascal Staccini; Patrick Fénichel; Giulia Chinetti
Journal:  Obes Surg       Date:  2017-06       Impact factor: 4.129

3.  Postprandial Dynamics of Proglucagon Cleavage Products and Their Relation to Metabolic Health.

Authors:  Robert Wagner; Sabine S Eckstein; Louise Fritsche; Katsiaryna Prystupa; Sebastian Hörber; Hans-Ulrich Häring; Andreas L Birkenfeld; Andreas Peter; Andreas Fritsche; Martin Heni
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-29       Impact factor: 6.055

Review 4.  Insights on glicentin, a promising peptide of the proglucagon family.

Authors:  Juliette Raffort; Fabien Lareyre; Damien Massalou; Patrick Fénichel; Patricia Panaïa-Ferrari; Giulia Chinetti
Journal:  Biochem Med (Zagreb)       Date:  2017-06-15       Impact factor: 2.313

5.  Enteroendocrine-derived glucagon-like peptide-2 controls intestinal amino acid transport.

Authors:  Jennifer Lee; Jacqueline Koehler; Bernardo Yusta; Jasmine Bahrami; Dianne Matthews; Mahroukh Rafii; Paul B Pencharz; Daniel J Drucker
Journal:  Mol Metab       Date:  2017-01-17       Impact factor: 7.422

Review 6.  Proglucagon-Derived Peptides as Therapeutics.

Authors:  Ryan A Lafferty; Finbarr P M O'Harte; Nigel Irwin; Victor A Gault; Peter R Flatt
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-18       Impact factor: 5.555

Review 7.  Neurohormonal Changes in the Gut-Brain Axis and Underlying Neuroendocrine Mechanisms following Bariatric Surgery.

Authors:  Eirini Martinou; Irena Stefanova; Evangelia Iosif; Angeliki M Angelidi
Journal:  Int J Mol Sci       Date:  2022-03-19       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.